These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12856383

  • 1. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P, Gastonguay MR.
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [Abstract] [Full Text] [Related]

  • 2. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

  • 3. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ, Pons G, Autret-Leca E, Allegaert K, Boccard E.
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX, Jiang ZG, Ding HZ, Liu YH.
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
    Schaefer HG, Stass H, Wedgwood J, Hampel B, Fischer C, Kuhlmann J, Schaad UB.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
    [Abstract] [Full Text] [Related]

  • 6. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY, Rivory LP, Clarke SJ, McLachlan AJ.
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D, Mondick JT, Jayaraman B, Thompson PA, Blaney SM, Bernstein M, Bond M, Champagne M, Fossler MJ, Barrett JS.
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [Abstract] [Full Text] [Related]

  • 8. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
    Jolling K, Perez Ruixo JJ, Hemeryck A, Vermeulen A, Greway T.
    Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
    [Abstract] [Full Text] [Related]

  • 9. A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
    Variol P, Nguyen L, Tranchand B, Puozzo C.
    Eur J Clin Pharmacol; 2002 Oct; 58(7):467-76. PubMed ID: 12389069
    [Abstract] [Full Text] [Related]

  • 10. The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride.
    Krishna R, Krishnaswami S, Kittner B, Sankoh AJ, Jensen BK.
    Biopharm Drug Dispos; 2004 Dec; 25(9):373-87. PubMed ID: 15517550
    [Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetic investigation of actinomycin-D in children and young adults.
    Mondick JT, Gibiansky L, Gastonguay MR, Skolnik JM, Cole M, Veal GJ, Boddy AV, Adamson PC, Barrett JS.
    J Clin Pharmacol; 2008 Jan; 48(1):35-42. PubMed ID: 18094218
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.
    Hong Y, Shaw PJ, Nath CE, Yadav SP, Stephen KR, Earl JW, McLachlan AJ.
    Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254
    [Abstract] [Full Text] [Related]

  • 13. Application of routine monitoring data for determination of the population pharmacokinetics and enteral bioavailability of phenytoin in neonates and infants with seizures.
    Al Za'abi M, Lanner A, Xiaonian X, Donovan T, Charles B.
    Ther Drug Monit; 2006 Dec; 28(6):793-9. PubMed ID: 17164696
    [Abstract] [Full Text] [Related]

  • 14. Clonidine disposition in children; a population analysis.
    Potts AL, Larsson P, Eksborg S, Warman G, Lönnqvist PA, Anderson BJ.
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y, Somsaard P, Petcharattana S.
    J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241
    [Abstract] [Full Text] [Related]

  • 16. Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.
    Rapp HJ, Molnár V, Austin S, Krohn S, Gädeke V, Motsch J, Boos K, Williams DG, Gustafsson U, Huledal G, Larsson LE.
    Paediatr Anaesth; 2004 Sep; 14(9):724-32. PubMed ID: 15330953
    [Abstract] [Full Text] [Related]

  • 17. Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species.
    Cox SK, Cottrell MB, Smith L, Papich MG, Frazier DL, Bartges J.
    J Vet Pharmacol Ther; 2004 Jun; 27(3):139-46. PubMed ID: 15189299
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM, Milovanovic JR.
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [Abstract] [Full Text] [Related]

  • 19. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
    Terziivanov D, Atanasova I, Dimitrova V.
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of oral busulfan in children.
    Schiltmeyer B, Klingebiel T, Schwab M, Mürdter TE, Ritter CA, Jenke A, Ehninger G, Gruhn B, Würthwein G, Boos J, Hempel G.
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.